Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma
Clinical trial NCT03846427 · COMPLETED
Trial details
- NCT number
- NCT03846427
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-19
- Primary completion
- 2022-05-04
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.